BDBM361943 US10221178, Compound 2-37::{4-[(2S)-2-{[9-ethyl-8-(2- methylpyrimidin-5-yl)-9H-purin- 6-yl]amino}butanoyl]-(R and S)- morpholin-3-yl}methanol
SMILES: CC[C@H](Nc1ncnc2n(CC)c(nc12)-c1cnc(C)nc1)C(=O)N1CCOCC1CO
InChI Key: InChIKey=DQLKTMXMMGROFD-LYKKTTPLSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (Homo sapiens (Human)) | BDBM361943 (US10221178, Compound 2-37 | {4-[(2S)-2-{[9-ethyl-8...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 64 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column... | US Patent US10221178 (2019) BindingDB Entry DOI: 10.7270/Q20C4Z2D | |||||||||||
More data for this Ligand-Target Pair |